(PRWEB) May 14, 2012
CHI, the California Healthcare Institute, announced today the nomination of Robert “Chip” Hance, senior vice president, vascular, Abbott, to serve as chairman-elect. Additionally, Nicole Beckstrand has been promoted to vice president of marketing and communications. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.
“State and federal regulations are having a tremendous impact on the ability of biomedical companies to conduct business in California,” said David L. Gollaher, Ph.D., CHI president and CEO. “Strong industry leadership is the key to guiding our approach to the important issues we face today, from FDA regulation to government coverage and reimbursement for innovative products.”
Robert “Chip” Hance was elected to the CHI Board of Directors in January 2007. He is senior vice president, vascular, Abbott, a global, broad-based healthcare company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. Hance joined Abbott in 1989 and held a number of management positions in Abbott’s diagnostics division. For the past decade, Hance has held leadership positions at Abbott’s California-based businesses and currently leads Abbott’s vascular business, which is head quartered in Santa Clara, Calif. In 2002, he began in the interventional cardiology field as head of Abbott’s newly founded vascular devices division, based in Redwood City, Calif., where he oversaw the development and launch of several key new cardiovascular technologies. Prior to his current position, Hance was the head of Abbott’s Diabetes Care business, based in Alameda, Calif., from 2007 to 2008. Currently, more than 6,500 employees work in 10 Abbott divisions throughout California. Before joining Abbott, Hance was an associate fellow at Harvard Business School and a product development engineer at Procter & Gamble. He earned a bachelor's degree in chemical engineering from the Massachusetts Institute of Technology and a master's degree in business administration from Harvard Business School.
Beckstrand joined CHI as director of communications in August 2007. She has 15 years of experience in public relations, corporate communications and public affairs in the life sciences and high tech industries in San Diego. Prior to joining CHI, she served as manager of public relations for Biosite Incorporated (now Alere Inc.) a leading provider of rapid medical diagnostics and antibody development technologies. Previously, Beckstrand served the City of San Diego as a business and community outreach specialist in the Economic Development Department and worked at several life sciences and high tech public relations and investor relations firms in San Diego. Beckstrand is a member of the Public Relations Society of America and Meeting Professionals International. She holds a bachelor’s degree in communication from the University of California, San Diego.
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare and Facebook.